From April 1, 2021 to June 30, 2021, the company has repurchased 1,624,546 shares, representing 1.62% for $5.7 million. With this, the company has completed the repurchase of 3,250,193 shares, representing 3.23% for $12 million under the buyback announced on November 4, 2020.
BioDelivery Sciences International, Inc.
Equities
BDSI
US09060J1060
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+54.42% | 803B | |
-7.14% | 351B | |
+18.21% | 324B | |
+10.63% | 303B | |
+16.77% | 243B | |
+2.25% | 228B | |
+10.97% | 217B | |
+6.38% | 164B | |
-4.19% | 155B |